*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.
Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|
☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
☉ UNPD: Universal Natural Products Database [PMID: 23638153].
☉ StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
☉ TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
☉ TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
☉ TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
☉ TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
☉ HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
☉ MetaboLights: a metabolomics database [PMID: 27010336].
☉ FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].
Organism ID | NP ID | Organism Material Preparation | Organism Part | NP Quantity (Standard) | NP Quantity (Minimum) | NP Quantity (Maximum) | Quantity Unit | Reference |
---|
☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
☉ DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
☉ PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
☉ FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT144 | Individual Protein | Telomerase reverse transcriptase | Homo sapiens | Inhibition | = | 60.0 | % | PMID[572764] |
NPT144 | Individual Protein | Telomerase reverse transcriptase | Homo sapiens | Inhibition | = | 29.0 | % | PMID[572764] |
NPT71 | Cell Line | HEK293 | Homo sapiens | LC50 | = | 1200000.0 | nM | PMID[572776] |
NPT616 | Cell Line | MDCK | Canis lupus familiaris | LC50 | = | 1500000.0 | nM | PMID[572776] |
NPT5112 | Individual Protein | 30S ribosomal protein S12 | Streptomyces coelicolor (strain ATCC BAA-471 / A3(2) / M145) | Inhibition | = | 80.0 | % | PMID[572783] |
NPT1182 | Cell Line | J774.A1 | Mus musculus | CC50 | = | 53.33 | ug.mL-1 | PMID[572785] |
NPT113 | Cell Line | RAW264.7 | Mus musculus | IC50 | > | 100000.0 | nM | PMID[572793] |
NPT189 | Cell Line | Vero | Chlorocebus aethiops | CC50 | = | 53300.0 | nM | PMID[572796] |
NPT50 | Individual Protein | Tyrosyl-DNA phosphodiesterase 1 | Homo sapiens | IC50 | = | 21000000.0 | nM | PMID[572809] |
NPT317 | Uncleic Acid | Nucleic Acid | MIC | > | 100000.0 | nM | PMID[572756] | |
NPT317 | Uncleic Acid | Nucleic Acid | Kd | = | 1640.0 | nM | PMID[572757] | |
NPT317 | Uncleic Acid | Nucleic Acid | Kd | = | 1580.0 | nM | PMID[572757] | |
NPT317 | Uncleic Acid | Nucleic Acid | Kd | = | 5330.0 | nM | PMID[572757] | |
NPT317 | Uncleic Acid | Nucleic Acid | Kd | = | 1700.0 | nM | PMID[572757] | |
NPT317 | Uncleic Acid | Nucleic Acid | Kd | = | 400.0 | nM | PMID[572757] | |
NPT27 | Others | Unspecified | C50 | = | 0.32 | uM | PMID[572758] | |
NPT27 | Others | Unspecified | Uptake at C50 | = | 3.9 | n.a. | PMID[572758] | |
NPT27 | Others | Unspecified | Kill at C50 | = | 61.0 | % | PMID[572758] | |
NPT27 | Others | Unspecified | LD90 | = | 0.78 | uM | PMID[572758] | |
NPT24 | Organism | Human immunodeficiency virus 1 | Human immunodeficiency virus 1 | K | = | 43000.0 | M-1 | PMID[572759] |
NPT16 | Organism | Staphylococcus aureus | Staphylococcus aureus | MIC | = | 1000.0 | nM | PMID[572760] |
NPT19 | Organism | Escherichia coli | Escherichia coli | MIC | = | 3000.0 | nM | PMID[572760] |
NPT20529 | NON-MOLECULAR | NON-PROTEIN TARGET | n.a. | MIC | = | 560.0 | nM | PMID[572760] |
NPT317 | Uncleic Acid | Nucleic Acid | Kd | = | 3830.0 | nM | PMID[572761] | |
NPT317 | Uncleic Acid | Nucleic Acid | Kd | = | 440.0 | nM | PMID[572761] | |
NPT317 | Uncleic Acid | Nucleic Acid | Kd | = | 12600.0 | nM | PMID[572761] | |
NPT317 | Uncleic Acid | Nucleic Acid | Kd | = | 5850.0 | nM | PMID[572761] | |
NPT4383 | Uncleic Acid | Ribosomal RNA A-site | Kd | = | 200.0 | nM | PMID[572762] | |
NPT16 | Organism | Staphylococcus aureus | Staphylococcus aureus | MIC | = | 3000.0 | nM | PMID[572763] |
NPT19 | Organism | Escherichia coli | Escherichia coli | MIC | = | 6000.0 | nM | PMID[572763] |
NPT2 | Others | Unspecified | Inhibition | = | 0.0 | % | PMID[572764] | |
NPT35 | Others | n.a. | Kd | = | 200.0 | nM | PMID[572765] | |
NPT79 | Organism | Bacillus subtilis | Bacillus subtilis | Kd | = | 50000.0 | nM | PMID[572766] |
NPT317 | Uncleic Acid | Nucleic Acid | Frel | = | 0.41 | n.a. | PMID[572766] | |
NPT4383 | Uncleic Acid | Ribosomal RNA A-site | Kd | = | 100.0 | nM | PMID[572767] | |
NPT317 | Uncleic Acid | Nucleic Acid | IC50 | = | 600.0 | nM | PMID[572767] | |
NPT5110 | Organism | Meriones unguiculatus | Meriones unguiculatus | Activity | = | 14.0 | % | PMID[572768] |
NPT5110 | Organism | Meriones unguiculatus | Meriones unguiculatus | Activity | = | 17.6 | % | PMID[572768] |
NPT4383 | Uncleic Acid | Ribosomal RNA A-site | Kd | = | 390.0 | nM | PMID[572769] | |
NPT19 | Organism | Escherichia coli | Escherichia coli | Activity | = | 40.0 | % | PMID[572770] |
NPT19 | Organism | Escherichia coli | Escherichia coli | Activity | = | 70.0 | % | PMID[572770] |
NPT19 | Organism | Escherichia coli | Escherichia coli | Activity | = | 55.0 | % | PMID[572770] |
NPT19 | Organism | Escherichia coli | Escherichia coli | MIC | = | 0.25 | ug.mL-1 | PMID[572771] |
NPT19 | Organism | Escherichia coli | Escherichia coli | MIC | = | 128.0 | ug.mL-1 | PMID[572771] |
NPT1521 | Organism | Stenotrophomonas maltophilia | Stenotrophomonas maltophilia | MIC | = | 256.0 | ug.mL-1 | PMID[572771] |
NPT1521 | Organism | Stenotrophomonas maltophilia | Stenotrophomonas maltophilia | MIC | = | 64.0 | ug.mL-1 | PMID[572771] |
NPT20529 | NON-MOLECULAR | NON-PROTEIN TARGET | n.a. | MIC | = | 250.0 | ug.mL-1 | PMID[572772] |
NPT2900 | Organism | Bifidobacterium longum | Bifidobacterium longum | MIC | = | 250.0 | ug.mL-1 | PMID[572772] |
NPT2901 | Organism | Bifidobacterium thermophilum | Bifidobacterium thermophilum | MIC | = | 250.0 | ug.mL-1 | PMID[572772] |
NPT20529 | NON-MOLECULAR | NON-PROTEIN TARGET | n.a. | MIC | = | 500.0 | ug.mL-1 | PMID[572772] |
NPT20529 | NON-MOLECULAR | NON-PROTEIN TARGET | n.a. | MIC | = | 125.0 | ug.mL-1 | PMID[572772] |
NPT2900 | Organism | Bifidobacterium longum | Bifidobacterium longum | MIC | = | 500.0 | ug.mL-1 | PMID[572772] |
NPT2901 | Organism | Bifidobacterium thermophilum | Bifidobacterium thermophilum | MIC | = | 500.0 | ug.mL-1 | PMID[572772] |
NPT2900 | Organism | Bifidobacterium longum | Bifidobacterium longum | MIC | = | 125.0 | ug.mL-1 | PMID[572772] |
NPT2900 | Organism | Bifidobacterium longum | Bifidobacterium longum | MIC | = | 62.5 | ug.mL-1 | PMID[572772] |
NPT19 | Organism | Escherichia coli | Escherichia coli | Activity | = | 50.0 | % | PMID[572770] |
NPT19 | Organism | Escherichia coli | Escherichia coli | MIC | = | 3.0 | ug.mL-1 | PMID[572773] |
NPT16 | Organism | Staphylococcus aureus | Staphylococcus aureus | MIC | = | 1.0 | ug.mL-1 | PMID[572773] |
NPT2 | Others | Unspecified | Kd | = | 370.0 | nM | PMID[572774] | |
NPT2 | Others | Unspecified | Kd | = | 980.0 | nM | PMID[572774] | |
NPT2 | Others | Unspecified | Kcat | = | 0.19 | /s | PMID[572775] | |
NPT2 | Others | Unspecified | Km | = | 16900.0 | nM | PMID[572775] | |
NPT2 | Others | Unspecified | Kcat/Km | = | 1.12 | 10^4/M/s | PMID[572775] | |
NPT2 | Others | Unspecified | Km | = | 51100.0 | nM | PMID[572775] | |
NPT2 | Others | Unspecified | Kcat | = | 0.304 | /s | PMID[572775] | |
NPT2 | Others | Unspecified | Kcat/Km | = | 5.95 | 10^3/M/s | PMID[572775] | |
NPT2 | Others | Unspecified | Vmax | = | 0.183 | microM/s | PMID[572775] | |
NPT2 | Others | Unspecified | Vmax | = | 0.292 | microM/s | PMID[572775] | |
NPT4383 | Uncleic Acid | Ribosomal RNA A-site | Ka | = | 3.9 | 10'-5/M | PMID[572776] | |
NPT317 | Uncleic Acid | Nucleic Acid | Activity | = | 40.0 | % | PMID[572776] | |
NPT317 | Uncleic Acid | Nucleic Acid | Activity | = | 1.62 | % | PMID[572776] | |
NPT27 | Others | Unspecified | LC50 | = | 1400000.0 | nM | PMID[572776] | |
NPT32 | Organism | Mus musculus | Mus musculus | LD50 | = | 80.0 | mg.kg-1 | PMID[572776] |
NPT19 | Organism | Escherichia coli | Escherichia coli | MIC | = | 22000.0 | nM | PMID[572776] |
NPT19 | Organism | Escherichia coli | Escherichia coli | IC50 | = | 56.0 | nM | PMID[572776] |
NPT317 | Uncleic Acid | Nucleic Acid | Kd | < | 12000.0 | nM | PMID[572777] | |
NPT19 | Organism | Escherichia coli | Escherichia coli | MIC | = | 64.0 | ug.mL-1 | PMID[572778] |
NPT19 | Organism | Escherichia coli | Escherichia coli | MIC | = | 4.0 | ug.mL-1 | PMID[572778] |
NPT19 | Organism | Escherichia coli | Escherichia coli | MIC | = | 0.5 | ug.mL-1 | PMID[572778] |
NPT19 | Organism | Escherichia coli | Escherichia coli | MIC | = | 1.0 | ug.mL-1 | PMID[572778] |
NPT317 | Uncleic Acid | Nucleic Acid | Activity | = | 2.0 | % | PMID[572779] | |
NPT317 | Uncleic Acid | Nucleic Acid | Activity | = | 12.0 | % | PMID[572779] | |
NPT317 | Uncleic Acid | Nucleic Acid | Activity | = | 63.9 | % | PMID[572779] | |
NPT317 | Uncleic Acid | Nucleic Acid | Activity | = | 0.51 | /s | PMID[572779] | |
NPT2905 | Organism | Nocardia farcinica | Nocardia farcinica | MIC | > | 1024.0 | ug.mL-1 | PMID[572780] |
NPT2905 | Organism | Nocardia farcinica | Nocardia farcinica | MIC | = | 8.0 | ug.mL-1 | PMID[572780] |
NPT633 | Organism | Leishmania donovani | Leishmania donovani | IC50 | > | 100000.0 | nM | PMID[572781] |
NPT841 | Organism | Leishmania major | Leishmania major | IC50 | = | 25000.0 | nM | PMID[572781] |
NPT634 | Organism | Leishmania amazonensis | Leishmania amazonensis | IC50 | = | 19000.0 | nM | PMID[572781] |
NPT633 | Organism | Leishmania donovani | Leishmania donovani | IC50 | > | 50000.0 | nM | PMID[572781] |
NPT16 | Organism | Staphylococcus aureus | Staphylococcus aureus | MIC | = | 1.0 | ug.mL-1 | PMID[572782] |
NPT19 | Organism | Escherichia coli | Escherichia coli | MIC | = | 3.0 | ug.mL-1 | PMID[572782] |
NPT2908 | Organism | Streptomyces coelicolor | Streptomyces coelicolor | MIC | = | 0.1 | ug.mL-1 | PMID[572783] |
NPT2908 | Organism | Streptomyces coelicolor | Streptomyces coelicolor | MIC | = | 0.3 | ug.mL-1 | PMID[572783] |
NPT2908 | Organism | Streptomyces coelicolor | Streptomyces coelicolor | MIC | = | 0.8 | ug.mL-1 | PMID[572783] |
NPT2908 | Organism | Streptomyces coelicolor | Streptomyces coelicolor | MIC | = | 2.0 | ug.mL-1 | PMID[572783] |
NPT2908 | Organism | Streptomyces coelicolor | Streptomyces coelicolor | MIC | = | 3.0 | ug.mL-1 | PMID[572783] |
NPT2 | Others | Unspecified | Inhibition | > | 80.0 | % | PMID[572783] | |
NPT1022 | Organism | Cryptosporidium parvum | Cryptosporidium parvum | IC50 | = | 711.0 | nM | PMID[572784] |
NPT1022 | Organism | Cryptosporidium parvum | Cryptosporidium parvum | Activity | = | 95.0 | % | PMID[572784] |
NPT1022 | Organism | Cryptosporidium parvum | Cryptosporidium parvum | Activity | = | 96.4 | % | PMID[572784] |
NPT1022 | Organism | Cryptosporidium parvum | Cryptosporidium parvum | Activity | < | 2.0 | % | PMID[572784] |
NPT1022 | Organism | Cryptosporidium parvum | Cryptosporidium parvum | Inhibition | = | 40.0 | % | PMID[572784] |
NPT1022 | Organism | Cryptosporidium parvum | Cryptosporidium parvum | Activity | > | 80.0 | % | PMID[572784] |
NPT1022 | Organism | Cryptosporidium parvum | Cryptosporidium parvum | Activity | = | 90.0 | % | PMID[572784] |
NPT1022 | Organism | Cryptosporidium parvum | Cryptosporidium parvum | Activity | = | 85.0 | % | PMID[572784] |
NPT633 | Organism | Leishmania donovani | Leishmania donovani | Inhibition | = | 123.92 | % | PMID[572785] |
NPT633 | Organism | Leishmania donovani | Leishmania donovani | IC50 | = | 24.79 | ug.mL-1 | PMID[572785] |
NPT2 | Others | Unspecified | Ratio CC50/IC50 | = | 2.15 | n.a. | PMID[572785] | |
NPT633 | Organism | Leishmania donovani | Leishmania donovani | Inhibition | = | 46.7 | % | PMID[572785] |
NPT841 | Organism | Leishmania major | Leishmania major | EC50 | = | 4290.0 | nM | PMID[572786] |
NPT841 | Organism | Leishmania major | Leishmania major | EC50 | = | 3980.0 | nM | PMID[572786] |
NPT841 | Organism | Leishmania major | Leishmania major | Ratio EC50 | = | 1.0 | n.a. | PMID[572786] |
NPT20596 | PHENOTYPE | Hepatotoxicity | n.a. | HepSE_bilirubinemia | = | 0.0 | n.a. | PMID[572789] |
NPT20596 | PHENOTYPE | Hepatotoxicity | n.a. | HepSE_cholecystitis | = | 0.0 | n.a. | PMID[572789] |
NPT20596 | PHENOTYPE | Hepatotoxicity | n.a. | HepSE_cholelithiasis | = | 0.0 | n.a. | PMID[572789] |
NPT20596 | PHENOTYPE | Hepatotoxicity | n.a. | HepSE_cirrhosis | = | 0.0 | n.a. | PMID[572789] |
NPT20596 | PHENOTYPE | Hepatotoxicity | n.a. | HepSE_elevated liver function tests | = | 0.0 | n.a. | PMID[572789] |
NPT20596 | PHENOTYPE | Hepatotoxicity | n.a. | HepSE_hepatic failure | = | 0.0 | n.a. | PMID[572789] |
NPT20596 | PHENOTYPE | Hepatotoxicity | n.a. | HepSE_hepatic necrosis | = | 0.0 | n.a. | PMID[572789] |
NPT20596 | PHENOTYPE | Hepatotoxicity | n.a. | HepSE_hepatitis | = | 0.0 | n.a. | PMID[572789] |
NPT20596 | PHENOTYPE | Hepatotoxicity | n.a. | HepSE_hepatomegaly | = | 0.0 | n.a. | PMID[572789] |
NPT20596 | PHENOTYPE | Hepatotoxicity | n.a. | HepSE_jaundice | = | 0.0 | n.a. | PMID[572789] |
NPT20596 | PHENOTYPE | Hepatotoxicity | n.a. | HepSE_liver disease | = | 0.0 | n.a. | PMID[572789] |
NPT20596 | PHENOTYPE | Hepatotoxicity | n.a. | HepSE_liver fatty | = | 0.0 | n.a. | PMID[572789] |
NPT20596 | PHENOTYPE | Hepatotoxicity | n.a. | HepSE_liver function tests abnormal | = | 0.0 | n.a. | PMID[572789] |
NPT20596 | PHENOTYPE | Hepatotoxicity | n.a. | HepSE_Combined Scores | = | 0.0 | n.a. | PMID[572789] |
NPT1022 | Organism | Cryptosporidium parvum | Cryptosporidium parvum | EC50 | = | 65000.0 | nM | PMID[572790] |
NPT16 | Organism | Staphylococcus aureus | Staphylococcus aureus | MIC | = | 2.0 | ug.mL-1 | PMID[572791] |
NPT16 | Organism | Staphylococcus aureus | Staphylococcus aureus | MIC | > | 64.0 | ug.mL-1 | PMID[572791] |
NPT633 | Organism | Leishmania donovani | Leishmania donovani | GI | = | 46.7 | % | PMID[572792] |
NPT633 | Organism | Leishmania donovani | Leishmania donovani | IC50 | = | 85500.0 | nM | PMID[572793] |
NPT633 | Organism | Leishmania donovani | Leishmania donovani | IC50 | = | 62600.0 | nM | PMID[572793] |
NPT633 | Organism | Leishmania donovani | Leishmania donovani | IC50 | = | 41000.0 | nM | PMID[572793] |
NPT633 | Organism | Leishmania donovani | Leishmania donovani | IC50 | = | 24500.0 | nM | PMID[572793] |
NPT27 | Others | Unspecified | Ratio IC50 | > | 4.1 | n.a. | PMID[572793] | |
NPT27 | Others | Unspecified | IC50 | > | 100000.0 | nM | PMID[572793] | |
NPT27 | Others | Unspecified | Ratio IC50 | > | 1.6 | n.a. | PMID[572793] | |
NPT27 | Others | Unspecified | Ratio IC50 | > | 1.2 | n.a. | PMID[572793] | |
NPT27 | Others | Unspecified | Ratio IC50 | > | 2.4 | n.a. | PMID[572793] | |
NPT2 | Others | Unspecified | Selectivity ratio | = | 2.0 | n.a. | PMID[572794] | |
NPT20529 | NON-MOLECULAR | NON-PROTEIN TARGET | n.a. | MIC | > | 64.0 | ug.mL-1 | PMID[572795] |
NPT16 | Organism | Staphylococcus aureus | Staphylococcus aureus | MIC | > | 64.0 | ug.mL-1 | PMID[572795] |
NPT1228 | Organism | Streptococcus pyogenes | Streptococcus pyogenes | MIC | = | 64.0 | ug.mL-1 | PMID[572795] |
NPT20529 | NON-MOLECULAR | NON-PROTEIN TARGET | n.a. | MIC | = | 64.0 | ug.mL-1 | PMID[572795] |
NPT20529 | NON-MOLECULAR | NON-PROTEIN TARGET | n.a. | MIC | = | 32.0 | ug.mL-1 | PMID[572795] |
NPT1228 | Organism | Streptococcus pyogenes | Streptococcus pyogenes | MIC | = | 16.0 | ug.mL-1 | PMID[572795] |
NPT16 | Organism | Staphylococcus aureus | Staphylococcus aureus | MIC | = | 16.0 | ug.mL-1 | PMID[572795] |
NPT1277 | Organism | Staphylococcus epidermidis ATCC 12228 | Staphylococcus epidermidis ATCC 12228 | MIC | = | 2.0 | ug.mL-1 | PMID[572795] |
NPT633 | Organism | Leishmania donovani | Leishmania donovani | Inhibition | = | 46.0 | % | PMID[572796] |
NPT2 | Others | Unspecified | Ratio CC50/IC50 | = | 2.0 | n.a. | PMID[572796] | |
NPT633 | Organism | Leishmania donovani | Leishmania donovani | IC50 | = | 24800.0 | nM | PMID[572796] |
NPT1466 | Organism | Escherichia coli K12 | Escherichia coli K-12 | MIC | = | 113.0 | ug.mL-1 | PMID[572797] |
NPT19 | Organism | Escherichia coli | Escherichia coli | MIC | = | 4.0 | ug.mL-1 | PMID[572797] |
NPT18 | Organism | Pseudomonas aeruginosa | Pseudomonas aeruginosa | MIC | = | 113.0 | ug.mL-1 | PMID[572797] |
NPT16 | Organism | Staphylococcus aureus | Staphylococcus aureus | MIC | = | 4.0 | ug.mL-1 | PMID[572797] |
NPT2 | Others | Unspecified | IC50 | = | 10.42 | ug.mL-1 | PMID[572798] | |
NPT25608 | PROTEIN NUCLEIC-ACID COMPLEX | Bacterial 70S ribosome | Bacteria | IC50 | = | 0.03 | ug.mL-1 | PMID[572798] |
NPT2 | Others | Unspecified | IC50 | = | 0.57 | ug.mL-1 | PMID[572798] | |
NPT2 | Others | Unspecified | IC50 | = | 0.26 | ug.mL-1 | PMID[572798] | |
NPT2 | Others | Unspecified | IC50 | = | 5.83 | ug.mL-1 | PMID[572798] | |
NPT2 | Others | Unspecified | IC50 | = | 10.39 | ug.mL-1 | PMID[572798] | |
NPT4795 | Subcellular | Ribosome | IC50 | = | 9.78 | ug.mL-1 | PMID[572798] | |
NPT16 | Organism | Staphylococcus aureus | Staphylococcus aureus | MIC | = | 4.0 | ug.mL-1 | PMID[572798] |
NPT16 | Organism | Staphylococcus aureus | Staphylococcus aureus | MIC | > | 256.0 | ug.mL-1 | PMID[572798] |
NPT19 | Organism | Escherichia coli | Escherichia coli | MIC | = | 2.0 | ug.mL-1 | PMID[572798] |
NPT19 | Organism | Escherichia coli | Escherichia coli | MIC | = | 16.0 | ug.mL-1 | PMID[572798] |
NPT19 | Organism | Escherichia coli | Escherichia coli | MIC | = | 8.0 | ug.mL-1 | PMID[572798] |
NPT2 | Others | Unspecified | Inhibition | = | 10.0 | % | PMID[572799] | |
NPT2 | Others | Unspecified | IC50 | = | 773000.0 | nM | PMID[572799] | |
NPT2 | Others | Unspecified | IC50 | = | 345000.0 | nM | PMID[572799] | |
NPT2 | Others | Unspecified | IC50 | = | 543000.0 | nM | PMID[572799] | |
NPT2 | Others | Unspecified | Kd | = | 138000.0 | nM | PMID[572799] | |
NPT2 | Others | Unspecified | Kd | = | 44000.0 | nM | PMID[572799] | |
NPT2 | Others | Unspecified | Kd | = | 91200.0 | nM | PMID[572799] | |
NPT2 | Others | Unspecified | Kd | = | 133200.0 | nM | PMID[572799] | |
NPT2 | Others | Unspecified | Ratio | = | 1.0 | n.a. | PMID[572799] | |
NPT2 | Others | Unspecified | Kd | = | 167000.0 | nM | PMID[572799] | |
NPT2 | Others | Unspecified | Ratio | = | 1.2 | n.a. | PMID[572799] | |
NPT2 | Others | Unspecified | Activity | = | 61.0 | % | PMID[572799] | |
NPT841 | Organism | Leishmania major | Leishmania major | IC50 | > | 100000.0 | nM | PMID[572800] |
NPT19 | Organism | Escherichia coli | Escherichia coli | MIC | = | 4.0 | ug.mL-1 | PMID[572801] |
NPT16 | Organism | Staphylococcus aureus | Staphylococcus aureus | MIC | = | 2.0 | ug.mL-1 | PMID[572801] |
NPT173 | Organism | Klebsiella pneumoniae | Klebsiella pneumoniae | MIC | = | 2.0 | ug.mL-1 | PMID[572801] |
NPT747 | Organism | Acinetobacter baumannii | Acinetobacter baumannii | MIC | = | 4.0 | ug.mL-1 | PMID[572801] |
NPT18 | Organism | Pseudomonas aeruginosa | Pseudomonas aeruginosa | MIC | > | 64.0 | ug.mL-1 | PMID[572801] |
NPT1033 | Organism | Enterobacter cloacae | Enterobacter cloacae | MIC | > | 64.0 | ug.mL-1 | PMID[572801] |
NPT19 | Organism | Escherichia coli | Escherichia coli | MIC | > | 64.0 | ug.mL-1 | PMID[572801] |
NPT16 | Organism | Staphylococcus aureus | Staphylococcus aureus | MIC | > | 64.0 | ug.mL-1 | PMID[572801] |
NPT747 | Organism | Acinetobacter baumannii | Acinetobacter baumannii | MIC | > | 64.0 | ug.mL-1 | PMID[572801] |
NPT19 | Organism | Escherichia coli | Escherichia coli | MIC | = | 8.0 | ug.mL-1 | PMID[572801] |
NPT713 | Individual Protein | Bile salt export pump | Homo sapiens | IC50 | > | 1000000.0 | nM | PMID[572802] |
NPT633 | Organism | Leishmania donovani | Leishmania donovani | IC50 | > | 30000.0 | nM | PMID[572803] |
NPT1021 | Organism | Leishmania infantum | Leishmania infantum | IC50 | = | 136000.0 | nM | PMID[572803] |
NPT1021 | Organism | Leishmania infantum | Leishmania infantum | IC50 | = | 78500.0 | nM | PMID[572803] |
NPT1021 | Organism | Leishmania infantum | Leishmania infantum | IC50 | = | 165000.0 | nM | PMID[572803] |
NPT1021 | Organism | Leishmania infantum | Leishmania infantum | IC50 | = | 64100.0 | nM | PMID[572803] |
NPT1021 | Organism | Leishmania infantum | Leishmania infantum | IC50 | = | 87700.0 | nM | PMID[572803] |
NPT1021 | Organism | Leishmania infantum | Leishmania infantum | IC50 | = | 64900.0 | nM | PMID[572803] |
NPT1021 | Organism | Leishmania infantum | Leishmania infantum | IC50 | = | 142000.0 | nM | PMID[572803] |
NPT605 | Organism | Homo sapiens | Homo sapiens | DILI_severity_class | = | 0.0 | n.a. | PMID[572804] |
NPT1021 | Organism | Leishmania infantum | Leishmania infantum | IC50 | = | 427260.0 | nM | PMID[572805] |
NPT2 | Others | Unspecified | Kd | = | 5.0 | nM | PMID[572806] | |
NPT2 | Others | Unspecified | Kd | = | 6500.0 | nM | PMID[572806] | |
NPT2 | Others | Unspecified | Kd | = | 2800.0 | nM | PMID[572806] | |
NPT25608 | PROTEIN NUCLEIC-ACID COMPLEX | Bacterial 70S ribosome | Bacteria | IC50 | = | 0.03 | ug.mL-1 | PMID[572806] |
NPT19 | Organism | Escherichia coli | Escherichia coli | MIC | = | 4.0 | ug.mL-1 | PMID[572806] |
NPT2 | Others | Unspecified | IC50 | = | 6.0 | ug.mL-1 | PMID[572806] | |
NPT2 | Others | Unspecified | IC50 | = | 51.0 | ug.mL-1 | PMID[572806] | |
NPT2 | Others | Unspecified | Ratio IC50 | = | 1700.0 | n.a. | PMID[572806] | |
NPT2 | Others | Unspecified | Selectivity ratio | = | 1300.0 | n.a. | PMID[572806] | |
NPT2 | Others | Unspecified | Ratio IC50 | = | 200.0 | n.a. | PMID[572806] | |
NPT2 | Others | Unspecified | Selectivity ratio | = | 560.0 | n.a. | PMID[572806] | |
NPT2 | Others | Unspecified | IC50 | = | 142000.0 | nM | PMID[572807] | |
NPT25608 | PROTEIN NUCLEIC-ACID COMPLEX | Bacterial 70S ribosome | Bacteria | IC50 | = | 38.0 | nM | PMID[572807] |
NPT2 | Others | Unspecified | Ratio IC50 | = | 816.0 | n.a. | PMID[572807] | |
NPT2 | Others | Unspecified | Ratio IC50 | = | 315.0 | n.a. | PMID[572807] | |
NPT2 | Others | Unspecified | Ratio IC50 | = | 3737.0 | n.a. | PMID[572807] | |
NPT2 | Others | Unspecified | IC50 | = | 31000.0 | nM | PMID[572807] | |
NPT2 | Others | Unspecified | IC50 | = | 12000.0 | nM | PMID[572807] | |
NPT633 | Organism | Leishmania donovani | Leishmania donovani | IC50 | = | 19700.0 | nM | PMID[572808] |
NPT27 | Others | Unspecified | Inhibition | = | 4.0 | % | PMID[572810] | |
NPT20555 | ORGANISM | SARS-CoV-2 | Severe acute respiratory syndrome coronavirus 2 | IC50 | > | 20000.0 | nM | PMID[572811] |
NPT20555 | ORGANISM | SARS-CoV-2 | Severe acute respiratory syndrome coronavirus 2 | IC50 | > | 19952.62 | nM | PMID[572811] |
NPT633 | Organism | Leishmania donovani | Leishmania donovani | IC50 | = | 19700.0 | nM | PMID[572812] |
NPT28154 | PROTEIN NUCLEIC-ACID COMPLEX | 80S Ribosome | Homo sapiens | IC50 | = | 50.54 | ug.mL-1 | PMID[572798] |
☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.
Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC195969 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
1.0 | High Similarity | NPC176381 |
0.9759 | High Similarity | NPC214376 |
0.9759 | High Similarity | NPC314408 |
0.9759 | High Similarity | NPC477060 |
0.9759 | High Similarity | NPC123746 |
0.9759 | High Similarity | NPC43850 |
0.9759 | High Similarity | NPC314007 |
0.9651 | High Similarity | NPC315334 |
0.9639 | High Similarity | NPC313552 |
0.9157 | High Similarity | NPC263058 |
0.9036 | High Similarity | NPC315969 |
0.9 | High Similarity | NPC330590 |
0.8617 | High Similarity | NPC315036 |
0.8571 | High Similarity | NPC318258 |
0.8421 | Intermediate Similarity | NPC471628 |
0.8421 | Intermediate Similarity | NPC56298 |
0.7864 | Intermediate Similarity | NPC57436 |
0.7864 | Intermediate Similarity | NPC121479 |
0.7717 | Intermediate Similarity | NPC306838 |
0.7624 | Intermediate Similarity | NPC221148 |
0.7447 | Intermediate Similarity | NPC470282 |
0.7416 | Intermediate Similarity | NPC316807 |
0.7349 | Intermediate Similarity | NPC322801 |
0.7349 | Intermediate Similarity | NPC129100 |
0.7349 | Intermediate Similarity | NPC291650 |
0.7333 | Intermediate Similarity | NPC70574 |
0.7333 | Intermediate Similarity | NPC100204 |
0.7333 | Intermediate Similarity | NPC83248 |
0.7315 | Intermediate Similarity | NPC241597 |
0.7283 | Intermediate Similarity | NPC165119 |
0.7222 | Intermediate Similarity | NPC98750 |
0.7174 | Intermediate Similarity | NPC36927 |
0.7174 | Intermediate Similarity | NPC271772 |
0.7105 | Intermediate Similarity | NPC94319 |
0.697 | Remote Similarity | NPC328646 |
0.6882 | Remote Similarity | NPC471420 |
0.6771 | Remote Similarity | NPC192025 |
0.6771 | Remote Similarity | NPC125253 |
0.6771 | Remote Similarity | NPC253975 |
0.6701 | Remote Similarity | NPC83839 |
0.6667 | Remote Similarity | NPC150557 |
0.6667 | Remote Similarity | NPC470284 |
0.6606 | Remote Similarity | NPC317534 |
0.6517 | Remote Similarity | NPC327486 |
0.6517 | Remote Similarity | NPC223174 |
0.6517 | Remote Similarity | NPC327753 |
0.6346 | Remote Similarity | NPC470283 |
0.6311 | Remote Similarity | NPC208537 |
0.6311 | Remote Similarity | NPC270005 |
0.631 | Remote Similarity | NPC34877 |
0.631 | Remote Similarity | NPC290179 |
0.6293 | Remote Similarity | NPC313813 |
0.625 | Remote Similarity | NPC20035 |
0.6211 | Remote Similarity | NPC314772 |
0.6211 | Remote Similarity | NPC314968 |
0.6161 | Remote Similarity | NPC59589 |
0.6147 | Remote Similarity | NPC188453 |
0.6147 | Remote Similarity | NPC42320 |
0.6118 | Remote Similarity | NPC317023 |
0.61 | Remote Similarity | NPC476523 |
0.6092 | Remote Similarity | NPC17455 |
0.6036 | Remote Similarity | NPC314413 |
0.6036 | Remote Similarity | NPC239705 |
0.6036 | Remote Similarity | NPC314398 |
0.6022 | Remote Similarity | NPC474468 |
0.6 | Remote Similarity | NPC244539 |
0.6 | Remote Similarity | NPC472025 |
0.5982 | Remote Similarity | NPC62845 |
0.5982 | Remote Similarity | NPC166242 |
0.5982 | Remote Similarity | NPC322449 |
0.5982 | Remote Similarity | NPC189854 |
0.5982 | Remote Similarity | NPC92874 |
0.5938 | Remote Similarity | NPC313762 |
0.5929 | Remote Similarity | NPC10897 |
0.5929 | Remote Similarity | NPC325900 |
0.5904 | Remote Similarity | NPC67660 |
0.5904 | Remote Similarity | NPC130683 |
0.5904 | Remote Similarity | NPC145112 |
0.5904 | Remote Similarity | NPC157514 |
0.5904 | Remote Similarity | NPC323361 |
0.5904 | Remote Similarity | NPC269166 |
0.5904 | Remote Similarity | NPC242073 |
0.5904 | Remote Similarity | NPC246558 |
0.5904 | Remote Similarity | NPC107914 |
0.5904 | Remote Similarity | NPC58629 |
0.5904 | Remote Similarity | NPC165198 |
0.5904 | Remote Similarity | NPC89145 |
0.5897 | Remote Similarity | NPC314306 |
0.5887 | Remote Similarity | NPC68327 |
0.5833 | Remote Similarity | NPC303727 |
0.5795 | Remote Similarity | NPC477757 |
0.5795 | Remote Similarity | NPC472026 |
0.5795 | Remote Similarity | NPC477755 |
0.5795 | Remote Similarity | NPC477763 |
0.5795 | Remote Similarity | NPC477750 |
0.5795 | Remote Similarity | NPC477762 |
0.5795 | Remote Similarity | NPC477753 |
0.5778 | Remote Similarity | NPC6848 |
0.5745 | Remote Similarity | NPC476694 |
0.5745 | Remote Similarity | NPC28959 |
0.5745 | Remote Similarity | NPC476695 |
0.5745 | Remote Similarity | NPC137554 |
0.5745 | Remote Similarity | NPC255535 |
0.5745 | Remote Similarity | NPC299603 |
0.5745 | Remote Similarity | NPC476696 |
0.5745 | Remote Similarity | NPC285014 |
0.5726 | Remote Similarity | NPC139857 |
0.5714 | Remote Similarity | NPC315980 |
0.5701 | Remote Similarity | NPC61894 |
0.5701 | Remote Similarity | NPC475603 |
0.5663 | Remote Similarity | NPC326533 |
0.5652 | Remote Similarity | NPC475918 |
0.5638 | Remote Similarity | NPC475694 |
0.5638 | Remote Similarity | NPC473710 |
0.5635 | Remote Similarity | NPC75839 |
0.5632 | Remote Similarity | NPC219040 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC195969 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
1.0 | High Similarity | NPD5795 | Approved |
1.0 | High Similarity | NPD5797 | Approved |
1.0 | High Similarity | NPD5794 | Approved |
1.0 | High Similarity | NPD5796 | Clinical (unspecified phase) |
1.0 | High Similarity | NPD5798 | Approved |
0.9759 | High Similarity | NPD3203 | Approved |
0.9759 | High Similarity | NPD3207 | Approved |
0.9759 | High Similarity | NPD3209 | Approved |
0.9759 | High Similarity | NPD2698 | Approved |
0.9759 | High Similarity | NPD3201 | Approved |
0.9759 | High Similarity | NPD3202 | Approved |
0.9759 | High Similarity | NPD3208 | Approved |
0.9639 | High Similarity | NPD3200 | Clinical (unspecified phase) |
0.9 | High Similarity | NPD5377 | Approved |
0.9 | High Similarity | NPD5381 | Approved |
0.9 | High Similarity | NPD5378 | Approved |
0.8602 | High Similarity | NPD4282 | Approved |
0.8421 | Intermediate Similarity | NPD4835 | Approved |
0.8421 | Intermediate Similarity | NPD4837 | Approved |
0.8421 | Intermediate Similarity | NPD4838 | Approved |
0.8421 | Intermediate Similarity | NPD4836 | Approved |
0.8182 | Intermediate Similarity | NPD5376 | Approved |
0.7864 | Intermediate Similarity | NPD35 | Approved |
0.7864 | Intermediate Similarity | NPD4833 | Approved |
0.7624 | Intermediate Similarity | NPD1450 | Approved |
0.7624 | Intermediate Similarity | NPD1449 | Approved |
0.7349 | Intermediate Similarity | NPD9033 | Approved |
0.7349 | Intermediate Similarity | NPD9030 | Approved |
0.7349 | Intermediate Similarity | NPD9031 | Approved |
0.7349 | Intermediate Similarity | NPD9032 | Approved |
0.7315 | Intermediate Similarity | NPD3731 | Phase 3 |
0.729 | Intermediate Similarity | NPD2690 | Discontinued |
0.7212 | Intermediate Similarity | NPD2700 | Approved |
0.72 | Intermediate Similarity | NPD6428 | Approved |
0.7182 | Intermediate Similarity | NPD4832 | Approved |
0.7182 | Intermediate Similarity | NPD4831 | Approved |
0.7182 | Intermediate Similarity | NPD4830 | Approved |
0.7105 | Intermediate Similarity | NPD4826 | Approved |
0.7105 | Intermediate Similarity | NPD4828 | Approved |
0.7105 | Intermediate Similarity | NPD4827 | Approved |
0.7045 | Intermediate Similarity | NPD67 | Phase 2 |
0.7045 | Intermediate Similarity | NPD9034 | Approved |
0.6957 | Remote Similarity | NPD6436 | Phase 3 |
0.6792 | Remote Similarity | NPD8045 | Clinical (unspecified phase) |
0.6637 | Remote Similarity | NPD3204 | Clinical (unspecified phase) |
0.66 | Remote Similarity | NPD3716 | Discontinued |
0.6517 | Remote Similarity | NPD9445 | Approved |
0.6486 | Remote Similarity | NPD6941 | Approved |
0.6476 | Remote Similarity | NPD881 | Approved |
0.6239 | Remote Similarity | NPD7141 | Clinical (unspecified phase) |
0.6239 | Remote Similarity | NPD7140 | Approved |
0.6239 | Remote Similarity | NPD7139 | Approved |
0.6211 | Remote Similarity | NPD9435 | Approved |
0.6211 | Remote Similarity | NPD9434 | Approved |
0.614 | Remote Similarity | NPD8087 | Discontinued |
0.6095 | Remote Similarity | NPD1447 | Phase 3 |
0.6095 | Remote Similarity | NPD1446 | Phase 3 |
0.6078 | Remote Similarity | NPD4759 | Clinical (unspecified phase) |
0.5977 | Remote Similarity | NPD6123 | Approved |
0.5963 | Remote Similarity | NPD2255 | Approved |
0.595 | Remote Similarity | NPD8346 | Approved |
0.595 | Remote Similarity | NPD8347 | Approved |
0.595 | Remote Similarity | NPD8345 | Approved |
0.5904 | Remote Similarity | NPD895 | Approved |
0.5904 | Remote Similarity | NPD892 | Phase 3 |
0.5904 | Remote Similarity | NPD893 | Approved |
0.5904 | Remote Similarity | NPD887 | Approved |
0.5904 | Remote Similarity | NPD890 | Clinical (unspecified phase) |
0.5904 | Remote Similarity | NPD891 | Phase 3 |
0.5904 | Remote Similarity | NPD889 | Approved |
0.5904 | Remote Similarity | NPD894 | Approved |
0.5904 | Remote Similarity | NPD888 | Phase 3 |
0.5897 | Remote Similarity | NPD6430 | Approved |
0.5897 | Remote Similarity | NPD6429 | Approved |
0.5826 | Remote Similarity | NPD8174 | Phase 2 |
0.5783 | Remote Similarity | NPD2269 | Approved |
0.5778 | Remote Similarity | NPD1457 | Discontinued |
0.5773 | Remote Similarity | NPD372 | Clinical (unspecified phase) |
0.576 | Remote Similarity | NPD591 | Approved |
0.576 | Remote Similarity | NPD577 | Phase 3 |
0.5739 | Remote Similarity | NPD8307 | Discontinued |
0.5728 | Remote Similarity | NPD394 | Phase 3 |
0.5663 | Remote Similarity | NPD905 | Approved |
0.5663 | Remote Similarity | NPD904 | Phase 3 |
0.5631 | Remote Similarity | NPD361 | Discontinued |
0.5625 | Remote Similarity | NPD389 | Phase 3 |
0.5603 | Remote Similarity | NPD8140 | Approved |
Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
☉ A: chemistry similarity;
☉ B: biological targets similarity;
☉ C: networks similarity;
☉ D: cell-based bioactivity similarity;
☉ E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.